Medical representatives offering cash to boost sales, says chemists body

Industry sources point out that cash offers to distributors is a common practice

Medical representatives offering cash to boost sales, says chemists body
The changes in the Prevention of Money Laundering Act would be a step towards cleaning up black money from the system
Aneesh Phadnis Mumbai
Last Updated : Aug 30 2018 | 8:29 AM IST
A chemists association from Maharashtra has alleged that medical representatives are offering cash to distributors and wholesalers to push sales.

In a letter to all the marketing heads of pharmaceutical companies earlier in the week, the Maharashtra State Chemists and Druggists Association (MSCDA) has demand an end to this malpractice. The association's letter does not name any company and does not specify amounts being offered to distributors.

The letter brings to fore unethical marketing practices by pharmaceutical companies and comes as the proposed government rules on marketing practices hangs fire. In its draft code in 2014 the department of pharmaceuticals had barred companies from giving cash, gifts or any other pecuniary benefits to distributors and retailers.  However the government is yet to finalise rules and penalties for its violation.

MSCDA president Hukamraj Mehta said company representatives are offering money to distributors to meet their sales targets. “ We request you to investigate the matter on top priority and issue necessary directions to the concerned managers and medical representatives to refrain from such unethical and unprincipled trade practices,” Mehta said in his letter.

Industry sources point out that cash offers to distributors is a common practice and chemists association protests may have been triggered by loss of business. “ Sales representatives are targeting distributors outside their zones to achieve targets and this leads to loss of business for some,” an industry expert said.

“Not all companies are indulging in cash offers. It all depends upon the culture of organisation. There are instances of companies taking action against staff too who indulge in such practices,” he said.


Kanchana TK, director general of Organisation of Pharmaceutical Producers of India (OPPI) said their member companies have not received MSCDA letter. The OPPI has already issued a code for its members which advocates ethical business practices and bars members from giving cash and gifts to healthcare professionals. The organisation said it is in process of revising the code and making it more stringent.  “ We have been championing for the much needed uniform code for pharmaceutical marketing practices that will set out basic ethical standards of responsible healthcare towards patients in the country,” she added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story